🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-part Phase 2 study to evaluate the efficacy and safety of a...
Status
Recruiting
Location
Site 0170-USA Mitchell Cancer Institute
Start Date
2022-02-17
Trial ID
NCT05128825
Treatments Being Tested
This is a Phase 1b open-label, multicenter study, evaluating the safety, to...
Status
Recruiting
Location
Site 0264
Start Date
2020-10-26
Trial ID
NCT04516447
Treatments Being Tested
This is a randomized, Phase 3 trial designed to evaluate the efficacy and s...
Status
Recruiting
Location
Site 0107
Start Date
2026-04-17
Trial ID
NCT07546500
Treatments Being Tested
This study is being done to test the safety and effectiveness of combining ...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2023-11-16
Trial ID
NCT06015659
This research was done to evaluate the safety and effectiveness of a drug c...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2024-05-01
Trial ID
NCT06351332
Treatments Being Tested
This is a Phase 1 open-label, multicenter study of ZN-c3 (also known as Aze...
Status
Completed
Location
Site 0102
Start Date
2019-11-01
Trial ID
NCT04158336
Treatments Being Tested
This is a Phase 1/2 study to evaluate the safety, clinical activity, pharma...
Status
Completed
Location
Arizona Oncology Associates (Wilmot HOPE) - USOR
Start Date
2022-01-27
Trial ID
NCT05198804
Treatments Being Tested
This early phase I trial aims to determine how cobimetinib, olaparib, onvan...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2019-08-01
Trial ID
NCT04005690
Treatments Being Tested
This research study is being done to investigate how Azenosertib affects tu...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2025-03-05
Trial ID
NCT06369155
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of azenose...
Status
Recruiting
Location
UT MD Anderson Cancer Center
Start Date
2025-02-03
Trial ID
NCT06364410